Protists, eukaryotic unicellular organisms, play a crucial role in aquatic microbial food webs. Phagotrophic protists or ...

STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.

Mitochondria possess their own mRNA translation system, mediated by specialized mitoribosomes. Dysregulation of mitochondrial translation disrupts metabolic homeostasis and is linked to various ...

Nicholas Richardson, DO, at Precision for Medicine, breaks down minimal residual disease and MRD negativity as FDA end points for faster myeloma approvals. Under this framework, MRD negativity is ...

The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

Waters has announced the completion of its acquisition of BD’s Biosciences and Diagnostic Solutions businesses.

FDA proposes MRD-negative and complete response endpoints to fast-track multiple myeloma drug approvals, pushing deeper molecular results over ORR.

Q4 2025 earnings call recap: clonoSEQ MRD growth, 2026 revenue guidance, margins, cash burn and risks—read now.

Danaher CorporationDHR is scheduled to release fourth-quarter 2025 results on Jan. 28, before market open. The Zacks Consensus Estimate for revenues is pegged at $6.79 billion, which indicates an ...

Detailed price information for Cytek Biosciences Inc (CTKB-Q) from The Globe and Mail including charting and trades.

Learn to analyze the Cash Flow Statement like a pro! See through accounting tricks, analyze free cash flow, and use key ratios to pick better stocks. Apple & IBM examples included. Another Minneapolis ...